Cargando…
CD276-CAR T cells and Dual-CAR T cells targeting CD276/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse models
BACKGROUND: Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in childhood, whose prognosis is still poor especially for metastatic, high-grade, and relapsed RMS. New treatments are urgently needed, especially systemic therapies. Chimeric Antigen Receptor T cells (CAR Ts) are very effect...
Autores principales: | Timpanaro, Andrea, Piccand, Caroline, Dzhumashev, Dzhangar, Anton-Joseph, Stenija, Robbi, Andrea, Moser, Janine, Rössler, Jochen, Bernasconi, Michele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625270/ https://www.ncbi.nlm.nih.gov/pubmed/37924157 http://dx.doi.org/10.1186/s13046-023-02838-3 |
Ejemplares similares
-
Surfaceome Profiling of Cell Lines and Patient-Derived Xenografts Confirm FGFR4, NCAM1, CD276, and Highlight AGRL2, JAM3, and L1CAM as Surface Targets for Rhabdomyosarcoma
por: Timpanaro, Andrea, et al.
Publicado: (2023) -
Quantum Dot-Based Screening Identifies F3 Peptide and Reveals Cell Surface Nucleolin as a Therapeutic Target for Rhabdomyosarcoma
por: Dzhumashev, Dzhangar, et al.
Publicado: (2022) -
Novel FGFR4-Targeting Single-Domain Antibodies for Multiple Targeted Therapies against Rhabdomyosarcoma
por: Alijaj, Nagjie, et al.
Publicado: (2020) -
Targeting CD276 by CAR-T cells induces regression of esophagus squamous cell carcinoma in xenograft mouse models
por: Xuan, Yujing, et al.
Publicado: (2021) -
The Role of CD276 in Cancers
por: Liu, Shengzhuo, et al.
Publicado: (2021)